For example, Jiang et al. demonstrated that a high level of lnc-EGFR in Tregs could enhance immunosuppression in hepatoma cells via activating AP-1/NF-AT1signaling [42]. This evidence concerns the gene NFASC and hepatocellular carcinoma.